G423-0451 Screening compound: 4-[7-(4-ethoxyphenyl)-8-oxo-7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]-N-(3-phenylpropyl)butanamide

G423-0451 Screening compound: 4-[7-(4-ethoxyphenyl)-8-oxo-7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]-N-(3-phenylpropyl)butanamide
G423-0451 Screening compound: 4-[7-(4-ethoxyphenyl)-8-oxo-7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]-N-(3-phenylpropyl)butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G423-0451
4-[7-(4-ethoxyphenyl)-8-oxo-7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]-N-(3-phenylpropyl)butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G423-0451

Molecular Formula

C26H29N5O3 (C26 H29 N5 O3)

Compound Name

4-[7-(4-ethoxyphenyl)-8-oxo-7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]-N-(3-phenylpropyl)butanamide

IUPAC name

4-[7-(4-ethoxyphenyl)-8-oxo-7H8H-[124]triazolo[43-a]pyrazin-3-yl]-N-(3-phenylpropyl)butanamide

SMILES

CCOc(cc1)ccc1N(C=Cn1c2nnc1CCCC(NCCCc1ccccc1)=O)C2=O

InChI

InChI=1S/C26H29N5O3/c1-2-34-22-15-13-21(14-16-22)30-18-19-31-23(28-29-25(31)26(30)33)11-6-12-24(32)27-17-7-10-20-8-4-3-5-9-20/h3-5,8-9,13-16,18-19H,2,6-7,10-12,17H2,1H3,(H,27,32)

InChI Key

DSTUJIXBLJJFBD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27140610

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

459.55

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.029

Distribution Coefficient, logD

2.029

Water Solubility, LogSw

-2.38

Polar Surface Area

70.533

Acid Dissociation Constant (pKa)

14.74

Base Dissociation Constant (pKb)

-4.87

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.80

G423-0451 in Drug Discovery

Included in Screening Libraries

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system

References: we are preparing a list of scientific research reports with G423-0451 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G423-0451?
Check Price and Availability of G423-0451, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G423-0451 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G423-0451
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G423-0451
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G423-0451 available by request